AI assistant
Sending…
GILEAD SCIENCES, INC. — Director's Dealing 2018
Apr 16, 2018
29828_dirs_2018-04-16_170b849c-8f71-4084-a45f-245a2835a191.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-04-13
Reporting Person: Cogan John Francis (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-04-13 | Common Stock | M | 5833 | $26.615 | Acquired | 58452 | Direct |
| 2018-04-13 | Common Stock | S | 5833 | $75.56 | Disposed | 52619 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-04-13 | Non-qualified Stock Option (Right to Buy) | $26.615 | M | 5833 | Disposed | 2018-05-08 | Common Stock (5833) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: Options vest quarterly over a period of one year from date of grant.
More from GILEAD SCIENCES, INC.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30